Andrew Bloecher

1.8k total citations
17 papers, 1.2k citations indexed

About

Andrew Bloecher is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Andrew Bloecher has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Oncology. Recurrent topics in Andrew Bloecher's work include Fungal and yeast genetics research (6 papers), Microtubule and mitosis dynamics (4 papers) and Epigenetics and DNA Methylation (3 papers). Andrew Bloecher is often cited by papers focused on Fungal and yeast genetics research (6 papers), Microtubule and mitosis dynamics (4 papers) and Epigenetics and DNA Methylation (3 papers). Andrew Bloecher collaborates with scholars based in United States, United Kingdom and Belgium. Andrew Bloecher's co-authors include Kelly Tatchell, Bruce E. Clurman, James M. Roberts, Guglielmo M. Venturi, Keith R. Loeb, Jonathan Grim, Markus Welcker, Jeffrey D. Singer, Aaron M. Neiman and Hiroyuki Tachikawa and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and The Journal of Cell Biology.

In The Last Decade

Andrew Bloecher

17 papers receiving 1.2k citations

Peers

Andrew Bloecher
Eric R. Greene United States
Irina Krykbaeva United States
Philippe Vaglio United States
Elaine Cheng United States
Jani Saarela Finland
Byung Hak Ha United States
Eric R. Greene United States
Andrew Bloecher
Citations per year, relative to Andrew Bloecher Andrew Bloecher (= 1×) peers Eric R. Greene

Countries citing papers authored by Andrew Bloecher

Since Specialization
Citations

This map shows the geographic impact of Andrew Bloecher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Bloecher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Bloecher more than expected).

Fields of papers citing papers by Andrew Bloecher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Bloecher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Bloecher. The network helps show where Andrew Bloecher may publish in the future.

Co-authorship network of co-authors of Andrew Bloecher

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Bloecher. A scholar is included among the top collaborators of Andrew Bloecher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Bloecher. Andrew Bloecher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
O’Donovan, Daniel H., Martin J. Packer, Ryan Greenwood, et al.. (2021). Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase. Bioorganic & Medicinal Chemistry Letters. 39. 127904–127904. 11 indexed citations
2.
Burke, Kathleen A., Barrett Nuttall, Daniel Karl, et al.. (2021). Novel Mechanisms of Acalabrutinib Resistance in Patients with Chronic Lymphocytic Leukemia By Whole Genome Methylome Sequencing. Blood. 138(Supplement 1). 4361–4361. 1 indexed citations
3.
Degorce, Sébastien L., Rana Anjum, Andrew Bloecher, et al.. (2019). Discovery of a Series of 5-Azaquinazolines as Orally Efficacious IRAK4 Inhibitors Targeting MyD88L265P Mutant Diffuse Large B Cell Lymphoma. Journal of Medicinal Chemistry. 62(21). 9918–9930. 17 indexed citations
4.
Young, Lucy A., Oona Delpuech, Brandon S. Willis, et al.. (2018). Abstract LB-263: Preclinical efficacy of the ATR inhibitor AZD6738 in combination with the BTK inhibitor acalabrutinib in ABC-DLBCL models. Cancer Research. 78(13_Supplement). LB–263. 3 indexed citations
5.
O’Neil, Jennifer, Yair Benita, Igor Feldman, et al.. (2016). An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies. Molecular Cancer Therapeutics. 15(6). 1155–1162. 227 indexed citations
6.
Guertin, Amy D., Melissa M. Martin, Brian S. Roberts, et al.. (2012). Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition. Cancer Cell International. 12(1). 45–45. 65 indexed citations
7.
Sathyanarayanan, Sriram, David Cunningham, Sabine Tejpar, et al.. (2012). Activity of the anti-IGF-1R antibody dalotuzumab (MK-0646) in KRAS-mutant colorectal cancer: Preclinical and clinical data.. Journal of Clinical Oncology. 30(15_suppl). 3587–3587. 3 indexed citations
8.
Chen, Xueyan, Yong Chi, Andrew Bloecher, et al.. (2004). N-Acetylation and Ubiquitin-Independent Proteasomal Degradation of p21Cip1. Molecular Cell. 16(5). 839–847. 95 indexed citations
9.
Kozubowski, Lukasz, et al.. (2003). A Bni4-Glc7 Phosphatase Complex That Recruits Chitin Synthase to the Site of Bud Emergence. Molecular Biology of the Cell. 14(1). 26–39. 64 indexed citations
10.
Welcker, Markus, Jeffrey D. Singer, Keith R. Loeb, et al.. (2003). Multisite Phosphorylation by Cdk2 and GSK3 Controls Cyclin E Degradation. Molecular Cell. 12(2). 381–392. 302 indexed citations
11.
Peggie, Mark, et al.. (2002). Essential functions of Sds22p in chromosome stability and nuclear localization of PP1. Journal of Cell Science. 115(1). 195–206. 48 indexed citations
12.
Tachikawa, Hiroyuki, Andrew Bloecher, Kelly Tatchell, & Aaron M. Neiman. (2001). A Gip1p–Glc7p phosphatase complex regulates septin organization and spore wall formation. The Journal of Cell Biology. 155(5). 797–808. 84 indexed citations
13.
Bloecher, Andrew, Guglielmo M. Venturi, & Kelly Tatchell. (2000). Anaphase spindle position is monitored by the BUB2 checkpoint. Nature Cell Biology. 2(8). 556–558. 97 indexed citations
14.
Venturi, Guglielmo M., et al.. (2000). Genetic Interactions Between GLC7, PPZ1 and PPZ2 in Saccharomyces cerevisiae. Genetics. 155(1). 69–83. 45 indexed citations
15.
Bloecher, Andrew & Kelly Tatchell. (2000). Dynamic Localization of Protein Phosphatase Type 1 in the Mitotic Cell Cycle of Saccharomyces cerevisiae. The Journal of Cell Biology. 149(1). 125–140. 63 indexed citations
16.
Bloecher, Andrew & Kelly Tatchell. (1999). Defects in Saccharomyces cerevisiae protein phosphatase type I activate the spindle/kinetochore checkpoint. Genes & Development. 13(5). 517–522. 53 indexed citations
17.
Baker, Stefanie H., et al.. (1997). Alanine-Scanning Mutagenesis of Protein Phosphatase Type 1 in the Yeast Saccharomyces cerevisiae. Genetics. 145(3). 615–626. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026